and Elizabeth Warren, D-Mass., said the company's decision to discontinue Levemir, a long-acting insulin, "failed to take into consideration patient access to affordable, long-acting insulin ...

There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.